You are asking us to speculate, I will speculate for you.
Lets assume that RCE gets through the next few years of trials, is really starting to show pedigree and management are still getting traction the way they are right now.
What might a BIG Pharma be willing to pay for Recce as a buyout, SENSIBLY considering the potential that Recce has worldwide, I think that BIG Pharma would jump on us at that point, or perhaps even earlier.
I estimate that at minimum Recce would attract a buyout of between $4 and $6 Billion dollars, sensibly considering benefit. Assuming the registry stays the same, being conservative with a buyout number we sell at $4 Billion Each share would be valued at $23.00 per share $23.00 * 173,787,847 shares = $3,996,890,481
I know that RECCE is not for sale, but if it were, this is what you could expect and more. RED
RCE Price at posting:
$1.34 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)